MSI-H/dMMR Solid Tumors
1 clinical trials · Condition
◉ Watch MSI-H/dMMR Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors (NCT03736889) | BeiGene | 2018-09-19 |
Track MSI-H/dMMR Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.